Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
Helena GbelcováSilvie RimpelováZdeněk KnejzlíkJana ŠáchováMichal KolářHynek StrnadVanda RepiskáWalter Cosimo D'AcuntoTomáš RumlLibor VítekPublished in: Lipids in health and disease (2017)
Our data indicate that the anticancer effects of statins observed in numerous studies to a large extent are mediated through isoprenoid intermediates of the mevalonate pathway, as they influence expression of genes involved in multiple intracellular pathways.